The Preclinical Design and Clinical Translation of TB Regimens (PReDicTR) Consortium has been awarded a $30.8M grant over five years to research the most effective treatment options for future clinical testing.
School researchers netted $36.7M from 65 grants, fueling efforts spanning drug discovery, bioengineering, pharmacokinetics, clinical pharmacy, and more.
A delegation from South Korea visited to sign a Memorandum of Understand (MOU) initiating potential collaborations between UCSF and Korean schools of pharmacy.
This ninth year of awards focuses on research advancing health and furthering understanding related to cancer, diabetes, HIV testing, immune response, and more.
The FDA announces the Centers of Excellence in Regulatory Science and Innovation (CERSI) renewals, granting up to $50M for UCSF’s joint effort with Stanford.